A muscular public communications strategy has been one of the cornerstones of US FDA Commissioner Scott Gottlieb's tenure as head of the agency. And he is now using his now using his PR skills to home in on a topic of public interest as the federal government slogs through its third week of the shutdown: medical product safety.
While sponsors have begun to wonder whether the government shutdown will ultimately impact their drug review clocks, Gottlieb has done...




